Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use

By Deliyannis G.   Jackson D.C.   Dyer W.   Bates J.   Coulter A.   Harling-McNabb L.   Brown L.E.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2058-2068

Elsevier

Access to resources Recommend Favorite

Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice

By Nobiron I.   Thompson I.   Brownlie J.   Collins M.E.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4226-4235

Elsevier

Access to resources Recommend Favorite

Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses

By Rajananthanan P.   Attard G.S.   Sheikh N.A.   Morrow W.J.W.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 715-730

Elsevier

Access to resources Recommend Favorite

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

By Hu G.-J.   Wang R.Y.-H.   Han D.-S.   Alter H.J.   Shih J.W.-K.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3160-3170

Elsevier

Access to resources Recommend Favorite

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

By Lu X.   Clements J.D.   Katz J.M.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1019-1029

Elsevier

Access to resources Recommend Favorite